Skip to main content
. 2022 Apr 5;12:5664. doi: 10.1038/s41598-022-08422-7

Figure 2.

Figure 2

Reduced Plpp3 expression protects against abdominal aortic aneurysm development. (A) Plasma cholesterol at baseline and post-4 week AngII were measured in WT (n = 7) and Plpp3+/− (n = 6) mice, *P < 0.001, Two-way ANOVA, Bonferroni t-test, all pairwise multiple comparison. (B) Abdominal aorta gene expression from WT (n = 6) and Plpp3+/− (n = 6) following AngII treatment. (C) Representative images of aortas from WT and Plpp3+/−. (D) Abdominal aortic diameter measurements of WT (n = 9) and Plpp3+/− (n = 6) were measured using ultrasound at baseline and 4 week AngII,*P < 0.001, #P < 0.05, Two-way ANOVA, Holm-Sidak, all pairwise multiple comparison. (E) Percent incidence of AAA in WT (n = 9) and Plpp3+/− (n = 6) mice treated with AngII for 4 weeks P = 0.068 by Fischer’s exact test.